NIMACIMAB

Approval Year

Name

Type

Language

NIMACIMAB

Official Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CANNABINOID RECEPTOR 1)HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.4 HEAVY CHAIN (1-444) (HOMO SAPIENS VH (IGHV1-69*08 (88%) (IGHD)-IGHJ3*01 (91%)) (8.8.10) (1-107)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(225))) (108-444)

Systematic Name

English

NIMACIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CNR1 (CANNABINOID RECEPTOR 1, CANN6, CNR)), HUMANIZED MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN HUMANIZED (1-444) (VH (HOMO SAPIENS IGHV1-69*02 (86.7%)-(IGHD)-IGHJ4*01 (90.9%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*0

Systematic Name

English

RYI-018

Code

English

IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN CANNABINOID RECEPTOR 1) (HUMAN-MUS MUSCULUS MONOCLONAL RYI-018 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RYI-018 .KAPPA.-CHAIN, DIMER

Systematic Name

English

JNJ-2463

Code

English

JNJ2463

Code

English

RYI018

Code

English

nimacimab [INN]

Common Name

English

Code System Code Type Description

USAN

FG-02